M. Schlemmer
Impact in
- Gastroenterology top 0.1%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 30
- Gastric Cancer Management and Outcomes 18
-
- Gastrointestinal Tumor Research and Treatment 27
- Co-authors
- Jean‐Yves Blay (10 shared papers)Paolo G. Casali (6 shared papers)Peter Reichardt (17 shared papers)Jaap Verweij (8 shared papers)Ian Judson (7 shared papers)M. van Glabbeke (4 shared papers)Peter Hohenberger (11 shared papers)John Zalcberg (2 shared papers)
In The Last Decade
M. Schlemmer
63 papers receiving 3.1k citations
M. Schlemmer's Hit Papers
Peers
Comparison fields: 5 of 98
- Gastroenterology 2.0k
- Pulmonary and Respiratory Medicine 2.2k
- Neurology 520
- Surgery 1.2k
- Oncology 557
Countries citing papers authored by M. Schlemmer
This map shows the geographic impact of M. Schlemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schlemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schlemmer more than expected).
Fields of papers citing papers by M. Schlemmer
This network shows the impact of papers produced by M. Schlemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schlemmer. The network helps show where M. Schlemmer may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Schlemmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours Hit paper breakdown → | 2006 | 654 |
| 2 | 2005 | 281 | |
| 3 | 2005 | 222 | |
| 4 | 2008 | 162 | |
| 5 | 2015 | 149 | |
| 6 | 2009 | 148 | |
| 7 | 2008 | 139 | |
| 8 | 2017 | 131 | |
| 9 | 2009 | 112 | |
| 10 | 2004 | 108 | |
| 11 | 2012 | 97 | |
| 12 | 2004 | 70 | |
| 13 | 2011 | 62 | |
| 14 | 2008 | 55 | |
| 15 | 2005 | 54 | |
| 16 | 2007 | 54 | |
| 17 | 2018 | 54 | |
| 18 | 2014 | 53 | |
| 19 | 2012 | 50 | |
| 20 | 2016 | 47 |
About M. Schlemmer
M. Schlemmer is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Surgery, Oncology and Molecular Biology, having authored 64 papers that have together received 3.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (30 papers), Gastrointestinal Tumor Research and Treatment (27 papers), Gastric Cancer Management and Outcomes (18 papers), Gastrointestinal disorders and treatments (10 papers), Vascular Tumors and Angiosarcomas (5 papers), Renal and related cancers (4 papers), Cardiac tumors and thrombi (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Gastroenterology (2.0k citations), Pulmonary and Respiratory Medicine (2.2k citations), Neurology (520 citations), Surgery (1.2k citations) and Oncology (557 citations). M. Schlemmer has collaborated with scholars based in Germany, France and Italy. Frequent co-authors include Jean‐Yves Blay, Paolo G. Casali, Peter Reichardt, Jaap Verweij, Ian Judson, M. van Glabbeke, Peter Hohenberger, John Zalcberg, Raf Sciot and Allan T. van Oosterom. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, International Journal of Hyperthermia and RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.